FusePaq Tabradol and Insulin aspart, recombinant Subcutaneous
Determining the interaction of FusePaq Tabradol and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: cyclobenzaprine
Brand name: Amrix, Comfort Pac with Cyclobenzaprine, Fexmid, Flexeril
Synonyms: Cyclobenzaprine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- FusePaq Tabradol-Insulin degludec
- FusePaq Tabradol-Insulin Degludec (U-100) Prefilled Pens
- FusePaq Tabradol-Insulin Degludec (U-100) Vials
- FusePaq Tabradol-Insulin Degludec (U-200) Prefilled Pens
- FusePaq Tabradol-Insulin degludec and liraglutide
- FusePaq Tabradol-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Fusilev
- Insulin aspart, recombinant Subcutaneous-Fusion
- Insulin aspart, recombinant Subcutaneous-Fusion Plus (Vitamin B Complex and Iron Combinations Tablets and Capsules)
- Insulin aspart, recombinant Subcutaneous-Fusion Plus (Vitamins (Multiple/Oral))
- Insulin aspart, recombinant Subcutaneous-Fuzeon
- Insulin aspart, recombinant Subcutaneous-Fuzeon Injection